| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/03/2003 | EP1339662A1 Novel estrogen receptor ligands and methods iii |
| 09/03/2003 | EP1339502A1 Method for producing a partial or complete active ingredient coating on and in implants and onplants |
| 09/03/2003 | EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 09/03/2003 | EP1339438A2 Methods for preventing transplant rejection in the eye |
| 09/03/2003 | EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 09/03/2003 | EP1339420A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/03/2003 | EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines |
| 09/03/2003 | EP1339407A1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease |
| 09/03/2003 | EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 09/03/2003 | EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 09/03/2003 | EP1339399A2 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 09/03/2003 | EP1339398A2 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing compounds |
| 09/03/2003 | EP1339385A1 Skin cream stimulating the surface bloodstream |
| 09/03/2003 | EP1339349A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 09/03/2003 | EP1339294A1 Nutritional composition for an immune condition |
| 09/03/2003 | EP1196414B1 Prodrugs of carbamate inhibitors of impdh |
| 09/03/2003 | EP1183046B1 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 09/03/2003 | EP1140048B1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases |
| 09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
| 09/03/2003 | EP1066287B1 Azatricyclic compounds |
| 09/03/2003 | EP1032381B1 Naringin and naringenin as preventive or treating agent for hepatic diseases |
| 09/03/2003 | EP0993454B1 Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 09/03/2003 | EP0984936B1 Cyanoguanidines as cell proliferation inhibitors |
| 09/03/2003 | EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives |
| 09/03/2003 | EP0934271B1 Substituted arylalkylamines as neurokinin antagonists |
| 09/03/2003 | EP0929533B1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 09/03/2003 | EP0925070B1 Antifungal combination therapy |
| 09/03/2003 | EP0910372B1 Pharmaceutical compositions containing mesembrine and related compounds |
| 09/03/2003 | EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 09/03/2003 | EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440423A Immunoadhesin for the prevention of rhinovirus infection |
| 09/03/2003 | CN1440418A Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 09/03/2003 | CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 09/03/2003 | CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440406A 黑皮质素受体配体 Melanocortin receptor ligands |
| 09/03/2003 | CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders |
| 09/03/2003 | CN1440403A Quinazoline ditosylate salt compounds |
| 09/03/2003 | CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2003 | CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides |
| 09/03/2003 | CN1440396A Colchinol derivatives as angiogenesis inhibitors |
| 09/03/2003 | CN1440395A COLCHINOL derivatives as vascular damaging agents |
| 09/03/2003 | CN1440390A Substituted diamide derivatives useful as motilin antagonists |
| 09/03/2003 | CN1440388A Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 09/03/2003 | CN1440387A Alpha crystalline form of perindopril tert-butyllamine salt |
| 09/03/2003 | CN1440386A Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 09/03/2003 | CN1440385A Pyrrole derivatives for treating AIDS |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1440293A Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 09/03/2003 | CN1440283A Combination of organic compounds |
| 09/03/2003 | CN1120167C Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles having an affinity for alpha and/or 5HTIA receptors |
| 09/03/2003 | CN1120166C New class of benzoporphyrin derivative photoactive compounds |
| 09/03/2003 | CN1120160C Isoxazole and cortonamide derivatives and their use as pharmaceuticals and disgnositics |
| 09/03/2003 | CN1120157C Substituted quinoline-2-carboxylic acid amidesuand their preparation and their use as medicaments and intermediate products |
| 09/03/2003 | CN1120154C 4-hydroxy-piperdine derivatives |
| 09/03/2003 | CN1120013C Medicine for baldness caused by liver and kidney dificiency and its preparation |
| 09/02/2003 | US6613932 Prostaglandin derivatives |
| 09/02/2003 | US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/02/2003 | US6613905 Chemokine receptor antagonists and methods of use therefor |
| 09/02/2003 | US6613879 FAP-activated anti-tumour compounds |
| 09/02/2003 | US6613878 PCNA binding substance |
| 09/02/2003 | US6613874 Melanocortin receptor ligands |
| 09/02/2003 | US6613803 Treating, preventing or ameliorating pain |
| 09/02/2003 | US6613801 Method for the synthesis of compounds of formula I and their uses thereof |
| 09/02/2003 | US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/02/2003 | US6613794 Inhibiting tumor necrosis factor alpha, treating eosinophil-related condition, treating inflammatory airway disorder |
| 09/02/2003 | US6613790 Prodrugs of COX-2 inhibitors |
| 09/02/2003 | US6613788 Transdermal patch to systemically deliver effective dose of histamine comprising histamine and controlled release preparation which releases drug over period of time sufficient to obtain stable elevated levels in circulating blood |
| 09/02/2003 | US6613787 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer |
| 09/02/2003 | US6613783 Non-systemic control of parasites |
| 09/02/2003 | US6613781 Potential use in the treatment of a variety of central nervous system disorders such as anxiety, depression, epilepsy, obsessive-compulsive disorders, migraine, congnitive disorders, sleep disorders and schizophrenia |
| 09/02/2003 | US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors |
| 09/02/2003 | US6613772 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 09/02/2003 | US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands |
| 09/02/2003 | US6613769 Tryptase inhibitors |
| 09/02/2003 | US6613768 Treatment of female arousal disorder |
| 09/02/2003 | US6613763 Use of molindone to treat oppositional defiant disorder and conduct disorder |
| 09/02/2003 | US6613753 Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| 09/02/2003 | US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents |
| 09/02/2003 | US6613563 Viral vectors with modified tropism |
| 09/02/2003 | US6613544 Osteoprotegerin |
| 09/02/2003 | US6613345 Conjugates of sodium channel blockers and methods of using the same |
| 09/02/2003 | US6613322 Administering enzyme inhibitors |
| 09/02/2003 | CA2081709C Controlled release pharmaceutical compositions |
| 08/28/2003 | WO2003071281A2 Estrogen receptor interaction with a transcription factor |
| 08/28/2003 | WO2003070976A2 Methods for determining the influence of protein binding on antiretroviral activity |
| 08/28/2003 | WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070918A2 Rna interference by modified short interfering nucleic acid |
| 08/28/2003 | WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/28/2003 | WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070897A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 08/28/2003 | WO2003070881A2 RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYPROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070765A2 Growth hormone fusion protein |
| 08/28/2003 | WO2003070754A1 Histone deacetylase inhibitors and process for producing the same |
| 08/28/2003 | WO2003070751A2 Partial peptide mimetics and methods |
| 08/28/2003 | WO2003070750A2 Rna interference mediated inhibition of hepatitis c virus |